Here is the Academy of Finland introduction video to GeneCellNano – Gene, Cell and Nano Therapy Competence Cluster for the Treatment of Chronic Diseases.
GeneCellNano
Biotechnology Research
Academy of Finland Flagship consortium with focus on development of Advanced Therapy Medicinal Products.
About us
The GeneCellNano Flagship develops new biological drugs, biomarkers and diagnostics for diseases with unmet clinical needs. Our focus areas are cardiovascular diseases, age-related macular degeneration, and cancers of the brain, ovarian and bladder. The Flagship brings together an interdisciplinary team of top researchers specialized in biological Advanced Therapy Medicinal Products (ATMP) and nanotechnology for ATMP production.
- Sivusto
-
http://www.genecellnano.fi
External link for GeneCellNano
- Toimiala
- Biotechnology Research
- Yrityksen koko
- 201–500 työntekijää
- Päätoimipaikka
- Kuopio
- Tyyppi
- Voittoa tavoittelematon
- Perustettu
- 2019
- Erityisosaaminen
Sijainnit
-
Ensisijainen
Kuopio, FI
Päivitykset
-
GeneCellNano julkaisi tämän uudelleen
Making innovations is so social and fun with a great team - our students won the wildest idea & best idea prices with their teams 🌹🐎⌚️ #GeneCellNano #Tiedematka
-
GeneCellNano julkaisi tämän uudelleen
Itä-Suomen yliopiston tutkijat valottivat lihavuuden ja tulehduksen välisiä mekanismeja tutkimalla ihmisen rasvasolujen erittämiä viestinviejiä, solunulkoisia vesikkeleitä. Lihavuuteen liittyvä rasvakudoksen tulehdus kiihdytti vesikkelien erittymistä, mikä voi osaltaan vaikuttaa lihavuuden terveyshaittoihin. https://lnkd.in/dbHMWzQh
Lihavuuteen liittyvä tulehdus lisää rasvakudoksen vesikkelien erittymistä
uef.fi
-
GeneCellNano julkaisi tämän uudelleen
Our Professor Antti Poso was involved in research collaboration which developed a first-in-class small-molecule-based MKK4 inhibitor (HRX215). This inhibitor increased liver regeneration after hepatectomy in murine and porcine models. In addition, the inhibitor(HRX215) was safe, and it had excellent pharmacokinetics in humans in a phase I trials. #Drugdevelopment #liverdisease #kinases https://lnkd.in/dr2VGDd2
First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure
cell.com
-
🌟 A Special Kontinkangas Research Seminar featuring Professor William G. Kaelin Jr. and our very own Professor Seppo Ylä-Herttuala, was yesterday held at the University of Oulu. 🌟 🧬 Professor Seppo Ylä-Herttuala, a pioneer in gene therapy, illuminated the path from bench to bedside, emphasizing the translation of research into clinical practice. 👨🔬 Professor William G. Kaelin Jr., a Nobel Laureate renowned for his work on oxygen sensing and cancer, shared groundbreaking insights into cellular responses to oxygen availability. This event celebrated their Honorary Doctorates and showcased their impactful research, bridging cutting-edge science with real-world applications. Congratulations to them both! #GeneCellNano #honorarydoctorate #UniOulu #UniOuluConferment #NobelLaureate #GeneTherapy #UniversityofEasternFinland Photograph by Teija Luoto. In the photo, from the left: - Prof. Peppi Karppinen, University of Oulu, Dean of the Faculty of Biochemistry and Molecular Medicine, GCN PI -Prof. William Kaelin Jr., Dana-Farber Cancer Institute and Harvard Medical School, Howard Hughes Medical Institute, Boston - Prof. Johanna Myllyharju, University of Oulu and Chair of the Board of the Finnish Research Council - Prof. Seppo Ylä-Herttuala, University of Eastern Finland, GCN Director
-
Our flagship's Vice Director, Seppo Vainio, is part of the University of Oulu SweatIBDsensing project and pitching today in the final of the EIT Health Open Innovation IBD Challenge to develop better diagnostics and biomarkers for inflammatory bowel disease:
🎉 Exciting news! We are thrilled to introduce the companies selected for the Open Innovation IBD Challenge in collaboration with Takeda and KU Leuven. These companies will develop solutions for the early detection of flares and New biomarkers in inflammatory bowel disease. SweatIBDsensing - University of Oulu Fimo Health SANNO Biome Diagnostics NimBio Koios Care Leiden University Medical Center Ani Biome 🌟 Discover more about the programme: https://lnkd.in/eRGtXwa8
-
Last week, we had the Third Annual Meeting of the GeneCellNano Flagship to present the latest advancements in the flagship research projects, and to discuss the business opportunities arising from ATMP development. Thanks again to all the speakers, participants, and sponsors, for the excellent meeting! #finnishflagships
-
Congratulations to our flagship's Professor Marjo Yliperttula for her honorary doctorate from Aalto University!
We are thrilled to announce five new honorary doctors at Aalto🥳 The honorary doctors will be conferred on 14 June in the ceremonial conferment of doctoral degrees. Honorary doctorates 2024 of technology will be awarded to: Chief Executive Officer Tiina Alahuhta-Kasko, Marimekko Chief Technology Officer Alinikula Petteri, SAAB Finland Professor Ashok Kumar, Indian Institute of Technology Kanpur Professor Cecilia Tortajada, University of Glasgow Professor Marjo Yliperttula, University of Helsinki Huge congratulations! Read more: https://lnkd.in/gB-SPYVx
-
We're all ready for our annual meeting and looking forward to seeing all our members and collaborators!
Uusia biologisia lääkkeitä kroonisiin sairauksiin – GeneCellNano-lippulaivan kokous Helsingissä 18.-19.4.2024. Suomen Akatemian rahoittaman lippulaivan tieteellisessä kokouksessa tutkijat esittävät katsaukset geeni- ja soluterapian sekä nanoteknologian uusiin ratkaisuihin muun muassa sydämen vajaatoiminnan ja syöpätautien hoidossa ja biologisten lääkkeiden paremmassa kohdentamisessa. Lisäksi käsitellään uusien hoitomuotojen kaupallisia mahdollisuuksia sekä tutkimuskehitystä verkkokalvosairauksien ja sepelvaltimotaudin hoidossa ja kotimaisen koronarokotteen kehityksessä. https://lnkd.in/dk-YWwnv
Uusia biologisia lääkkeitä kroonisiin sairauksiin – GeneCellNano- lippulaivan kokous 18.-19.4.2024
uef.fi